Proteome analysis and its impact on the discovery of serological tumor markers
- 30 October 2001
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 313 (1-2) , 231-239
- https://doi.org/10.1016/s0009-8981(01)00677-5
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Tracking pathology with proteomics: Identification ofin vivo degradation products of αB-crystallinElectrophoresis, 2000
- Proteome analysis of mouse brain: Two-dimensional electrophoresis profiles of tissue proteins during the course of agingElectrophoresis, 2000
- Probability of hepatocellular carcinoma of small hepatocellular nodules undetectable by computed tomography during arterial portographyHepatology, 2000
- Regular review: Tumour markers in malignanciesBMJ, 2000
- Primary Mediastinal Malignant Germ Cell Tumour Single Institution Experience in Chinese Patients and correlation with specific alpha-fetoprotein bandsActa Oncologica, 1996
- Characterization of gene expression in clinical lung cancer materials by two‐dimensional polyacrylamide gel electrophoresisElectrophoresis, 1994
- Micropreparative two‐dimensional electrophoresis allowing the separation of samples containing milligram amounts of proteinsElectrophoresis, 1993
- Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patientsCancer, 1989
- α-fetoprotein monitoring in chinese patients with chronic hepatitis B virus infection: Role in the early detection of hepatocellular carcinomaHepatology, 1989
- Cirrhosis and the aetiology of hepatocellular carcinomaJournal of Hepatology, 1987